Trial Profile
A Double-Blind, Randomized, Placebo-Controlled Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Moderate to Severe Palmar Hyperhidrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2019
Price :
$35
*
At a glance
- Drugs Dexmecamylamine (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Atacama Therapeutics
- 18 Nov 2019 Status changed from recruiting to completed.
- 29 Jan 2018 Status changed from not yet recruiting to recruiting.
- 22 Jan 2018 New trial record